Related Experiment Video
Updated: Jul 12, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Role of mitogen-activated protein kinase phosphatases (MKPs) in cancer
1Program in Molecular Biology and Genetics, Department of Pathology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI 48201, USA. wug@karmanos.org
Abstract:
The mitogen-activated protein kinase (MAPK) phosphatases (MKPs) are a family of dual-specificity protein phosphatases that dephosphorylate both phospho-threonine and phospho-tyrosine residues in MAP kinases, including the c-Jun N-terminal protein kinase (JNK)/stress-activated protein kinase (SAPK), the p38 MAPK, and the extracellular signal-related kinase (ERK). Since phosphorylation is required for the activation of MAP kinases, dephosphorylation by MKPs inhibits MAPK activity, thereby negatively regulating MAPK signaling. It is known that deregulation of MAPK signaling is the most common alteration in human cancers. Recent studies have suggested that MKPs play an important role not only in the development of cancers, but also in the response of cancer cells to chemotherapy. Thus, understanding the roles of MKPs in the development of cancer and their impact on chemotherapy can be exploited for therapeutic benefits for the treatment of human cancer.
Insights
Mitogen-activated protein kinase (MAPK) phosphatases (MKPs) regulate MAPK signaling, which is crucial in cancer development and chemotherapy response. Understanding MKPs offers therapeutic potential for cancer treatment.
Area of Science:
- Molecular Biology
- Biochemistry
- Oncology
Background:
- Mitogen-activated protein kinase (MAPK) phosphatases (MKPs) are key regulators of MAPK signaling pathways.
- MAPK signaling is frequently dysregulated in human cancers.
- MKPs influence both cancer development and response to chemotherapy.
Purpose of the Study:
- To elucidate the role of MKPs in cancer development.
- To investigate the impact of MKPs on cancer cell chemotherapy response.
- To explore therapeutic strategies targeting MKPs for cancer treatment.
Main Methods:
- The study involves analyzing the dual-specificity protein phosphatase activity of MKPs.
- Investigating the dephosphorylation of key MAPKs like JNK, p38, and ERK.
- Reviewing recent literature on MKP involvement in cancer and chemotherapy.
Main Results:
- MKPs dephosphorylate and inhibit active MAPKs, thus negatively regulating MAPK signaling.
- Dysregulated MAPK signaling, often involving MKPs, is a common hallmark of human cancers.
- MKPs significantly impact cancer cell sensitivity to chemotherapeutic agents.
Conclusions:
- MKPs play a critical role in the pathogenesis of cancer.
- Targeting MKPs may enhance the efficacy of chemotherapy.
- Further understanding of MKPs can lead to novel cancer therapeutics.
Related Concept Videos
MAPK Signaling Cascades
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
